^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Oropharyngeal Cancer |
| Drug: | 5-fluorouracil (Thymidylate synthase inhibitor) + hydroxyurea (DNA synthesis inhibitor, Ribonucleotide reductase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
PRINCIPLES OF SYSTEMIC THERAPY FOR NON-NASOPHARYNGEAL CANCERS...(Lip, Oral Cavity, Oropharynx, Hypopharynx, Glottic Larynx, Supraglottic Larynx, Ethmoid Sinus, Maxillary Sinus, Occult Primary)...Useful in Certain Circumstances...5-FU/hydroxyurea
